SCIP

NOVEMBER 17, 2024

By simulating various design scenarios, GenAI accelerates the time it takes to bring new products to market, giving companies a competitive edge. Generative AI in Healthcare and Biotech In healthcare and biotechnology, GenAI is advancing drug discovery, diagnostics, and personalized medicine.

SCIP 40

SCIP Biotech Finance Innovation 40

Alpha Sense BI

MARCH 26, 2025

The IPO proceeds will go toward new production and research facilities worldwide, as well as expanding and upgrading existing factories in China. The IPO will gauge investor confidence in Indias food delivery and quick commerce space, especially as competition intensifies.

Commerce 59

Commerce Pharmaceutical Capital Biotech 59

Alpha Sense BI

AUGUST 30, 2023

As time goes on and more firms adopt AI tools, these capabilities will become even more essential to maintain a competitive advantage. Research shows that the AI in asset management market will grow at a staggering 34% CAGR through 2027.

Management 98

Management Biotech Due Diligence Algorithm 98

Alpha Sense BI

MAY 28, 2024

Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial market intelligence to gain a competitive advantage in the shifting landscape. Want to learn about how AlphaSense is empowering venture capital firms to accelerate their research efforts?

Capital 69

Capital Startups Biotech Due Diligence 69

Fuld

NOVEMBER 1, 2022

BOSTON – Nov 1, 2022 – Fuld & Company, a fast-growing research, analytics, and advisory business, today announced the appointment of Brad Thompson to the role of Advisory Board Member. Joining Fuld & Company is an exciting opportunity for me to work with global leaders in research, analytics, and intelligence ,” says Brad.

Pharmaceutical 52

Pharmaceutical Biotech Competitive Intelligence Competitive 52

Alpha Sense BI

MAY 5, 2023

2023 so far has revealed ideal conditions for dealmaking due to valuation resets, lessened competition for deals, and new assets coming to market. Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech.

Biotech 97

Biotech Capital Banking Startups 97

Alpha Sense BI

APRIL 29, 2024

This staggering statistic is representative of a transformative shift in the asset management space away from archaic research methods. Generative AI in venture capital streamlines workflows, reduces research and due diligence blind spots, and surfaces qualitative and quantitative insights to make data-driven decisions faster.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

APRIL 19, 2024

2023 was all about learning the use cases of genAI, as companies raced to introduce their own genAI offerings and capabilities into a fiercely competitive market (i.e. OpenAI’s ChatGPT ). Having proven to be a catalyst for business growth, genAI is projected to boast a $1.3 billion by 2030 with a CAGR of 23.1%

Technology 69

Technology Technology Retail Biotech 69

Alpha Sense BI

SEPTEMBER 1, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and have been on the market for at least nine to 13 years for more complex biotech drugs. In the age of information overload, you need reliable resources of insights to act quickly.

Pharmaceutical 52

Pharmaceutical Biotech Market Intelligence Competitive 52

Alpha Sense BI

MARCH 13, 2024

billion acquisition of Carmot Therapeutics, a clinical-stage biotechnology company with three GLP-1 assets in clinical production, including its CT-388 lead GLP-1 asset, in the hopes of gaining a competitive footing among Novo Nordisk and Eli Lilly’s products currently on the market (Ozempic, Wegovy, and Mounjaro, respectively).

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

MARCH 28, 2023

These first-hand perspectives are a critical addition to the secondary research that most professionals rely on in their market research, landscaping, and monitoring. Some are equipped with artificial intelligence capabilities that enable you to maximize and streamline your research, while others are more traditional in their approach.

Value Chain 52

Value Chain Biotech Research Competitive 52

Alpha Sense BI

JUNE 6, 2024

In today’s fast-paced and ever-evolving business landscape, staying ahead of the competition is more challenging yet more crucial than ever. Having a dedicated and comprehensive competitor analysis framework is critical, as is the ability to access all the competitive information you need in one place.

Competitor Analysis 40

Competitor Analysis Analysis Battlecard SWOT 40

Alpha Sense BI

APRIL 12, 2024

Expert interviews are a critical primary research tool that financial professionals often leverage to complete their investment process with last-mile, experiential insights. You think, ‘I have competitively a better methodology, a better framework, and you think the world will go on it.’ Similarly, expert calls fill particular roles.

Primary Research 52

Primary Research Advantage Advantage Research 52

Engage3

MAY 19, 2022

He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. while completing his postdoctoral research work with the University of California. Adi received his B.S.

Retail 52

Retail Capital Finance Biotech 52

Alpha Sense BI

JANUARY 25, 2023

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Netbasequid

FEBRUARY 22, 2021

In their paper on Deep Tech: The Great Wave of Innovation , BCG and Hello Tomorrow explain “what deep tech is, how it works, how different stakeholders can contribute to it, and how it can be harnessed for competitive advantage.” And they used NetBase Quid to inform their research. From here, the biotech world is your oyster.

Biotech 98

Biotech Innovation Intellectual Property Market Research 98

Alpha Sense BI

JANUARY 26, 2024

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices—as well as their intentions to scale their digital health solutions—to the masses in hopes of securing capital.

Biotech 59

Biotech Research Loss Algorithm 59

Alpha Sense BI

NOVEMBER 7, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and need to have been on the market for at least nine to 13 years for more complex biotech drugs. So, how could this become a problem for pharma companies in future QoQs?

Pharmaceutical 52

Pharmaceutical Biotech Innovation Technology 52

Sedulo

MARCH 15, 2023

As leaders in competitive strategy consulting, serving the life sciences community for the last 17 years, Sedulo Group can help you: Build a comprehensive view of the current and future competitive landscape. Obtain details on competitor clinical trial locations. Assess and benchmark enrollment timing.

Biotech 52

Biotech Competitive Landscape Pharmaceutical Benchmarking 52

Happy Market

MAY 9, 2022

Founded in 2007, Civic Science is a consumer intelligence research platform that polls millions of Americans each week covering thousands of topics. HubUX is a research operation platform for private panel management, qualitative automation including video audition questions, and surveys. Happy Researching! ??. [00:00:00].

Management 52

Management Entertainment Market Research Marketing Research 52

ATTEST

NOVEMBER 22, 2024

Boston’s innovation business ecosystem—from biotech startups in Kendall Square to fintech firms downtown—relies heavily on quality consumer insights. But with so many options for market research, from traditional focus group facilities to modern research platforms, finding the right partner isn’t always straightforward.

Market Research 52

Market Research Marketing Research Research Marketing 52

ATTEST

DECEMBER 20, 2024

From biotech startups in Torrey Pines to craft breweries in North Park, San Diego businesses rely on solid consumer insights to guide their decisions. The city has some well-establised traditional local agencies and modern research companies, each with their own expertise. Attest approaches market research differently.

Market Research 52

Market Research Marketing Research Research Marketing 52

Alpha Sense BI

FEBRUARY 6, 2025

Leading broker research in the AlphaSense platform referred to it as the biggest software deal of 2024. Billion (Closed in May 2024) This deal is an important one for the biotech sector, as it significantly expands Vertexs reach beyond their current focus on cystic fibrosis treatments into the market for kidney disease therapies.

Biotech 59

Biotech Capital Pharmaceutical Finance 59

Alpha Sense BI

NOVEMBER 9, 2022

Customers have multiyear R&D product road maps, and the competitive environment for customers is more challenging today than it’s ever been. M&A IPOs to watch in Pharma and Biotech. Annaliesa Anderson, Senior VP and Chief Scientific Officer for Bacterial Vaccines – Vaccine Research & Development Unit.

Sales 52

Sales Loss Capital Biotech 52

CIO

MARCH 4, 2025

As a business executive who has led ventures in areas such as space technology or data security and helped bridge research and industry, Ive seen first-hand how rapidly deep tech is moving from the lab into the heart of business strategy. For example, generative AI went from research milestone to widespread business adoption in barely a year.

Technology 442

Technology Technology Biotech Business 442